SUVRETTA CAPITAL MANAGEMENT, LLC - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q2 2022$2,937,000
+0.5%
300,0000.0%0.11%
+25.8%
Q1 2022$2,922,000
+0.5%
300,0000.0%0.09%
+58.9%
Q4 2021$2,907,000
+0.2%
300,0000.0%0.06%
+14.3%
Q3 2021$2,901,000
-0.7%
300,0000.0%0.05%
+11.4%
Q2 2021$2,922,000300,0000.04%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 400,000$4,040,0008.80%
GRITSTONE ASSET MANAGEMENT LLC 55,952$565,1150.72%
PERISCOPE CAPITAL INC. 776,797$7,845,6500.34%
GLAZER CAPITAL, LLC 1,254,733$12,6730.33%
MMCAP International Inc. SPC 250,000$2,525,0000.26%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$663,4590.14%
First Trust Capital Management L.P. 256,426$2,589,9030.14%
PICTON MAHONEY ASSET MANAGEMENT 274,995$2,7780.13%
KIM, LLC 200,000$2,0200.11%
Exos TFP Holdings LLC 35,970$363,2970.10%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders